Mickael Hiligsmann presented at the World Congress of Osteoporosis 2019
Mickael Hiligsmann co-chaired three symposiums and was speaker at four symposiums during the World Congress of Osteoporosis (WCO-ESCEO-IOF) that was held in Paris between 3 and 6 April 2019.
The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a not-for-profit organization, dedicated to a close interaction between clinical scientists dealing with bone, joint and muscle disorder, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of Osteoporosis and Osteoarthritis within the comprehensive perspective of health resources utilization.
The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. – www.esceo.org
Mickael Hiligsmann was invited to chair and speak during the symposium “Selection of relevant outcome in sarcopenia: a discrete-choice experiment” organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) during the International Conference on Frailty & Sarcopenia Research in Miami Beach, USA, on February 22nd, 2019. More information.
Also read
-
Turning brain research into an award-winning dance
As a PhD researcher, Kate Kondrateva studies how AI can improve the reliability of brain scans, and brought her findings to life in a prize-winning dance.
-
25 years of pioneering in dementia research
The Alzheimer Centre Limburg is celebrating its 25th anniversary this year. The three professors at the helm talk about their research.
-
The power of prevention: put on a bicycle helmet
As a neuropsychiatrist, David Linden sees the consequences of brain injury every day. He therefore advocates wearing a bicycle helmet to prevent serious harm.
